Anticoagulation after intracranial hemorrhage in brain tumors: Risk of recurrent hemorrhage and venous thromboembolism.

Carney, Brian J; Uhlmann, Erik J; Puligandla, Maneka; Mantia, Charlene; Weber, Griffin M; Neuberg, Donna S; Zwicker, Jeffrey I

Carney, Brian J; Uhlmann, Erik J; Puligandla, Maneka; Mantia, Charlene; Weber, Griffin M; Neuberg, Donna S; Zwicker, Jeffrey I.

Afiliação

Carney BJ; Division of Hemostasis and Thrombosis Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA.
Uhlmann EJ; Department of Neurology Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA.
Puligandla M; Department of Data Sciences Dana-Farber Cancer Institute Boston Massachusetts USA.
Mantia C; Division of Hematology and Oncology Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA.
Weber GM; Interdisciplinary Medicine and Biotechnology Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA.
Neuberg DS; Department of Data Sciences Dana-Farber Cancer Institute Boston Massachusetts USA.
Zwicker JI; Division of Hemostasis and Thrombosis Beth Israel Deaconess Medical Center and Harvard Medical School Boston Massachusetts USA.

Res Pract Thromb Haemost ; 4(5): 860-865, 2020 Jul.

Article em En | MEDLINE | ID: mdl-32685895

Palavras-chave

anticoagulation; brain tumors; intracranial hemorrhage; venous thromboembolism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Revista: Res Pract Thromb Haemost Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google